Oncoinvent selected to receive BIA funding from the Research Council of Norway
Oncoinvent is pleased to announce today that Oncoinvent has been selected to receive BIA project funding from the Research Council of Norway to help develop its lead product Radspherin®.BIA Call Results The Programme Board/Expert Committee for BIA has awarded funding to forty-six project(s) from among the one hundred and sixty grant applications submitted under the call for proposals with a deadline of 11.10.2017. A total of NOK 483 million was allocated to the call. Oncoinvent will now enter into contract negotiations with representatives from the Research Council to conclude the